Portal de investigação
Myofascial Pelvic Pain: Best Orientation and Clinical Practice. Position of the European Association of Urology Guidelines Panel on Chronic Pelvic Pain
Autores da FMUP
Participantes de fora da FMUP
- Baranowski, AP
- Berghmans, B
- Borovicka, J
- Cottrell, AM
- Dinis-Oliveira, P
- Elneil, S
- Hughes, J
- Messelink, BEJ
- Tidman, V
- Tornic, J
- Flink, I
- Parsons, BA
- Zumstein, V
- Engeler, DS
Unidades de investigação
Abstract
Context: Despite the high prevalence of a myofascial pain component in chronic pelvic pain (CPP) syndromes, awareness and management of this component are lacking among health care providers.Objective: To summarize the current state of the art for the management of myofascial pain in chronic primary pelvic pain syndromes (CPPPS) according to scientific research and input from experts from the European Association of Urology (EAU) guidelines panel on CPP.Evidence acquisition: A narrative review was undertaken using three sources: (1) infor-mation in the EAU guidelines on CPP; (2) information retrieved from the literature on research published in the past 3 yr on myofascial pelvic pain; and (3) expert opinion from panel members.Evidence synthesis: Studies confirm a high prevalence of a myofascial pain component in CPPPS. Examination of the pelvic floor muscles should follow published recommenda-tions to standardize findings and disseminate the procedure. Treatment of pelvic floor muscle dysfunction and pain in the context of CPP was found to contribute to CPP con-trol and is feasible via different physiotherapy techniques. A multidisciplinary approach is the most effective.Conclusions: Despite its high prevalence, the myofascial component of CPP has been underevaluated and undertreated to date. Myofascial pain must be assessed in all patients with CPPPS. Treatment of the myofascial pain component is relevant for global treatment success. Further studies are imperative to reinforce and better define the role of each physiotherapy technique in CPPPS.Patient summary: Pain and inflammation of the body's muscle and soft tissues (myofas-cial pain) frequently occurs in pelvic pain syndromes. Its presence must be evaluated to optimize management for each patient. If diagnosed, myofascial pain should be treated.(c) 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 2405-4569, 2405-4569
- Tipo:
- Review
- Páginas:
- 172-177
- Link para outro recurso:
- www.scopus.com
European Urology Focus Elsevier BV
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 8
Documentos
- Não há documentos
Filiações
Keywords
- Myofascial pain; Pelvic pain; Physical therapy
Proyectos asociados
Daily low-dose of Tadalafil improves pain and frequency in Bladder pain syndrome/Interstitial cystitis patients
Investigador Principal: Rui Miguel Correia de Almeida Pinto
Estudo Clínico Académico (Bladder) . 2020
Effect of intratrigonal botulinum toxin in patients with Bladder Pain Syndrome/Interstitial Cystitis: A 10 year, single center, retrospective study
Investigador Principal: Rui Miguel Correia de Almeida Pinto
Estudo Clínico Académico (Bladder Pain) . 2022
Silodosin improves pain and urinary frequency in Bladder Pain Syndrome/Interstitial Cystitis patients
Investigador Principal: Rui Miguel Correia de Almeida Pinto
Estudo Clínico Académico . 2022
Citar a publicação
Abreu P,Baranowski AP,Berghmans B,Borovicka J,Cottrell AM,Dinis P,Elneil S,Hughes J,Messelink B,Tidman V,Pinto R,Tornic J,Flink I,Parsons BA,Zumstein V,Engeler DS. Myofascial Pelvic Pain: Best Orientation and Clinical Practice. Position of the European Association of Urology Guidelines Panel on Chronic Pelvic Pain. Eur. Urol. Focus. 2023. 9(1):p. 172-177. IF:5,400. (1).
